2013 -- S 0428 | |
======= | |
LC01278 | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2013 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO INSURANCE - ORALLY ADMINISTERED ANTICANCER MEDICATION | |
|
      |
|
      |
     Introduced By: Senators Goldin, Ottiano, Jabour, Picard, and Cool Rumsey | |
     Date Introduced: February 26, 2013 | |
     Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1-1 |
     SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness |
1-2 |
Insurance Policies" is hereby amended by adding thereto the following section: |
1-3 |
     27-18-79. Orally administered anticancer medication - Coverage mandated. -- Every |
1-4 |
individual or group hospital or medical expense, insurance policy or individual or group hospital |
1-5 |
or medical services plan contract, plan or certificate of insurance delivered, issued for delivery, or |
1-6 |
renewed in this state shall provide coverage for prescribed, orally administered anticancer |
1-7 |
medications used to kill or slow the growth of cancerous cells on a basis no less favorable than |
1-8 |
intravenously administered or injected cancer medications that are covered as medical benefits. |
1-9 |
An increase in patient cost sharing for anticancer medications shall not be allowed to achieve |
1-10 |
compliance with this section. |
1-11 |
     SECTION 2. Chapter 27-19 of the General Laws entitled "Individual Health Insurance |
1-12 |
Coverage" is hereby amended by adding thereto the following section: |
1-13 |
     27-19-70. Orally administered anticancer medication – Coverage mandated. -- Every |
1-14 |
individual or group hospital or medical expense, insurance policy or individual or group hospital |
1-15 |
or medical services plan contract, plan or certificate of insurance delivered, issued for delivery, or |
1-16 |
renewed in this state shall provide coverage for prescribed, orally administered anticancer |
1-17 |
medications used to kill or slow the growth of cancerous cells on a basis no less favorable than |
1-18 |
intravenously administered or injected cancer medications that are covered as medical benefits. |
1-19 |
An increase in patient cost sharing for anticancer medications shall not be allowed to achieve |
1-20 |
compliance with this section. |
2-1 |
     SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service |
2-2 |
Corporations" is hereby amended by adding thereto the following section: |
2-3 |
     27-20-66. Orally administered anticancer medication – Coverage mandated. -- Every |
2-4 |
individual or group hospital or medical expense, insurance policy or individual or group hospital |
2-5 |
or medical services plan contract, plan or certificate of insurance delivered, issued for delivery, or |
2-6 |
renewed in this state shall provide coverage for prescribed, orally administered anticancer |
2-7 |
medications used to kill or slow the growth of cancerous cells on a basis no less favorable than |
2-8 |
intravenously administered or injected cancer medications that are covered as medical benefits. |
2-9 |
An increase in patient cost sharing for anticancer medications shall not be allowed to achieve |
2-10 |
compliance with this section. |
2-11 |
     SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance |
2-12 |
Organizations" is hereby amended by adding thereto the following section: |
2-13 |
      27-41-83. Orally administered anticancer medication – Coverage mandated. – |
2-14 |
Every individual or group hospital or medical expense, insurance policy or individual or group |
2-15 |
hospital or medical services plan contract, plan or certificate of insurance delivered, issued for |
2-16 |
delivery, or renewed in this state shall provide coverage for prescribed, orally administered |
2-17 |
anticancer medications used to kill or slow the growth of cancerous cells on a basis no less |
2-18 |
favorable than intravenously administered or injected cancer medications that are covered as |
2-19 |
medical benefits. An increase in patient cost sharing for anticancer medications shall not be |
2-20 |
allowed to achieve compliance with this section. |
2-21 |
     SECTION 5. This act shall take effect upon passage. |
      | |
======= | |
LC01278 | |
======== | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE - ORALLY ADMINISTERED ANTICANCER MEDICATION | |
*** | |
3-1 |
     This act would require insurance coverage for prescribed, orally administered anticancer |
3-2 |
medication just as there is coverage for intravenously administered or injected anticancer |
3-3 |
medications. |
3-4 |
     This act would take effect upon passage. |
      | |
======= | |
LC01278 | |
======= |